| Literature DB >> 32347761 |
Tamar Gomolin1, Abigail Cline2, Marc Zachary Handler2.
Abstract
Due to the COVID-19 pandemic, planned medical and surgical activities are being postponed. For the dermatology community, this interruption to the healthcare system can lead to delays in the diagnosis and treatment of melanoma. Neglecting melanoma during this crisis can result in increased mortality, morbidity and healthcare costs. With the COVID-19 pandemic evolving and no clear solutions in sight, it is time for the prospective evaluation of teledermatology. However, dermatologists should be cautious and continue seeing patients with pigmented lesions in person due to the necessity of early surgical intervention.Entities:
Keywords: COVID-19; delayed diagnosis; melanoma; public health; telemedicine
Mesh:
Year: 2020 PMID: 32347761 DOI: 10.1080/09546634.2020.1762844
Source DB: PubMed Journal: J Dermatolog Treat ISSN: 0954-6634 Impact factor: 3.359